210 related articles for article (PubMed ID: 11162720)
1. Dna adducts, mutations, and cancer 2000.
Hemminki K; Koskinen M; Rajaniemi H; Zhao C
Regul Toxicol Pharmacol; 2000 Dec; 32(3):264-75. PubMed ID: 11162720
[TBL] [Abstract][Full Text] [Related]
2. Environmental and chemical carcinogenesis.
Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
[TBL] [Abstract][Full Text] [Related]
3. Implications of results of molecular epidemiology on DNA adducts, their repair and mutations for mechanisms of human cancer.
Hemminki K; Thilly WG
IARC Sci Publ; 2004; (157):217-35. PubMed ID: 15055298
[TBL] [Abstract][Full Text] [Related]
4. DNA adduct burden and tobacco carcinogenesis.
Wiencke JK
Oncogene; 2002 Oct; 21(48):7376-91. PubMed ID: 12379880
[TBL] [Abstract][Full Text] [Related]
5. Carcinogen-DNA adducts as a biomarker for cancer risk.
Rundle A
Mutat Res; 2006 Aug; 600(1-2):23-36. PubMed ID: 16824556
[TBL] [Abstract][Full Text] [Related]
6. Creating context for the use of DNA adduct data in cancer risk assessment: I. Data organization.
Jarabek AM; Pottenger LH; Andrews LS; Casciano D; Embry MR; Kim JH; Preston RJ; Reddy MV; Schoeny R; Shuker D; Skare J; Swenberg J; Williams GM; Zeiger E
Crit Rev Toxicol; 2009; 39(8):659-78. PubMed ID: 19743944
[TBL] [Abstract][Full Text] [Related]
7. The uses of carcinogen-DNA adduct measurement in establishing mechanisms of mutagenesis and in chemoprevention.
Baird WM; Mahadevan B
Mutat Res; 2004 Mar; 547(1-2):1-4. PubMed ID: 15013693
[TBL] [Abstract][Full Text] [Related]
8. Methods for testing compounds for DNA adduct formation.
Reddy MV
Regul Toxicol Pharmacol; 2000 Dec; 32(3):256-63. PubMed ID: 11162719
[TBL] [Abstract][Full Text] [Related]
9. Correlation between biomarkers of human exposure to genotoxins with focus on carcinogen-DNA adducts.
Gyorffy E; Anna L; Kovács K; Rudnai P; Schoket B
Mutagenesis; 2008 Jan; 23(1):1-18. PubMed ID: 17989146
[TBL] [Abstract][Full Text] [Related]
10. High DNA damage by benzo[a]pyrene 7,8-diol-9,10-epoxide in bronchial epithelial cells from patients with lung cancer: comparison with lung parenchyma.
Rojas M; Marie B; Vignaud JM; Martinet N; Siat J; Grosdidier G; Cascorbi I; Alexandrov K
Cancer Lett; 2004 Apr; 207(2):157-63. PubMed ID: 15072824
[TBL] [Abstract][Full Text] [Related]
11. From fluorescence spectra to mutational spectra, a historical overview of DNA-reactive compounds.
Lawley PD
IARC Sci Publ; 1994; (125):3-22. PubMed ID: 7806320
[TBL] [Abstract][Full Text] [Related]
12. Mutation spectra induced by alpha-acetoxytamoxifen-DNA adducts in human DNA repair proficient and deficient (xeroderma pigmentosum complementation group A) cells.
McLuckie KI; Crookston RJ; Gaskell M; Farmer PB; Routledge MN; Martin EA; Brown K
Biochemistry; 2005 Jun; 44(22):8198-205. PubMed ID: 15924439
[TBL] [Abstract][Full Text] [Related]
13. DNA adduct formation by 7H-dibenzo[c,g]carbazole and its tissue- and organ-specific derivatives in Chinese hamster V79 cell lines stably expressing cytochrome P450 enzymes.
Gábelová A; Binková B; Valovicová Z; Srám RJ
Environ Mol Mutagen; 2004; 44(5):448-58. PubMed ID: 15534862
[TBL] [Abstract][Full Text] [Related]
14. Biological relevance of adduct detection to the chemoprevention of cancer.
Sharma RA; Farmer PB
Clin Cancer Res; 2004 Aug; 10(15):4901-12. PubMed ID: 15297390
[TBL] [Abstract][Full Text] [Related]
15. Body mass index modulates aromatic DNA adduct levels and their persistence in smokers.
Godschalk RW; Feldker DE; Borm PJ; Wouters EF; van Schooten FJ
Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):790-3. PubMed ID: 12163336
[TBL] [Abstract][Full Text] [Related]
16. DNA adducts as markers of exposure and risk.
Phillips DH
Mutat Res; 2005 Sep; 577(1-2):284-92. PubMed ID: 15922369
[TBL] [Abstract][Full Text] [Related]
17. Human biomonitoring: state of the art.
Angerer J; Ewers U; Wilhelm M
Int J Hyg Environ Health; 2007 May; 210(3-4):201-28. PubMed ID: 17376741
[TBL] [Abstract][Full Text] [Related]
18. Ultraviolet radiation-induced photoproducts in human skin DNA as biomarkers of damage and its repair.
Hemminki K; Xu G; Le Curieux F
IARC Sci Publ; 2001; 154():69-79. PubMed ID: 11220670
[TBL] [Abstract][Full Text] [Related]
19. Benzo[a]pyrene-7,8-quinone-3'-mononucleotide adduct standards for 32P postlabeling analyses: detection of benzo[a]pyrene-7,8-quinone-calf thymus DNA adducts.
Balu N; Padgett WT; Nelson GB; Lambert GR; Ross JA; Nesnow S
Anal Biochem; 2006 Aug; 355(2):213-23. PubMed ID: 16797471
[TBL] [Abstract][Full Text] [Related]
20. Immunological methods for detection of carcinogen-DNA damage in humans.
Santella RM
Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):733-9. PubMed ID: 10498391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
